Last update 25 Oct 2025

Heparin-derived oligosaccharide-C3

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Oligotropin, HDO-C3, HF 0420
+ [2]
Target
APP
Action
inhibitors
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors)
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOther Diseases
Active Indication-
Inactive Indication
Alzheimer DiseaseCentral nervous system injuryPeripheral Nervous System Diseases+ [1]
Originator Organization
Loyola University of ChicagoLoyola University of Chicago
Active Organization-
Inactive Organization
Newron Pharmaceuticals SpANewron Pharmaceuticals SpAHunter-Fleming Ltd.Loyola University of ChicagoLoyola University of Chicago
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Heparin-derived oligosaccharide-C3
Login to view more data
100 Translational Medicine associated with Heparin-derived oligosaccharide-C3
Login to view more data
100 Patents (Medical) associated with Heparin-derived oligosaccharide-C3
Login to view more data
100 Deals associated with Heparin-derived oligosaccharide-C3
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peripheral Nervous System DiseasesPhase 1
Italy
Loyola University of ChicagoLoyola University of Chicago
-
Peripheral Nervous System DiseasesPhase 1-
Newron Pharmaceuticals SpANewron Pharmaceuticals SpA
-
Alzheimer DiseasePreclinical
United Kingdom
Hunter-Fleming Ltd.
-
Central nervous system injuryPreclinical
United Kingdom
Hunter-Fleming Ltd.
-
StrokePreclinical
United Kingdom
Hunter-Fleming Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free